Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

0.00%

1.4¢ chimeric therapeutics limited

Charting Only, page-216

First 216 Last

Share
Profile

Follow
access

146 Posts.

18

15/06/23

17:01

Post #: 68307958
Share

Originally posted by dalts66: ↑

Gday slick.

The SPP has been extended until Friday the 16th June. Now the SPP price will be the lower of 4c or the last 5 day Vwap -5%

The Vwap seems to be held around 38.5c (thats slightly higher than last weeks Vwap) with some very low trades at times. So am thinking that range may be purpose made.

The chart looks ready to pop (one way or another) but I am guessing the range will stay till Friday.

Cover ya ears, cause this bit is almost Fundamental thinking. I am guessing if the SPP gets fully supported this market cap vs pipeline could give a good bounce. If the SPP fails to get enough funds for the rest of the year we may see a further dip.

Pipeline wise they have clues from very low dose amounts, that they may have the 1st CarT that works against solid tumors. Registration trial planned for when phase 1b trial ends.

Another drug, NK cells, us hitting arms now as well. Thats being paid for by another party.

So I reckon you could get those 100k shares just above the bottom of that range. And I reckon even if it doesnt pop the week after next, they are cheap enough to hold until next year when the real party should be started, driving the share price many multiples higher, which would compensate for the hold time.

Expand

Have just made my 'donation'.

If tomorrows Vwap is the same as today what do you estimate the share price for the offer would be issued at?

CHM Price at posting: 3.7¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 237 more messages in this thread...

First 216 Last

Add CHM (ASX) to my watchlist

(20min delay)
Last 1.4¢		Change 0.000(0.00%)		Mkt cap ! $12.67M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Charting Only, page-216

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Featured News

Charting Only, page-216

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Featured News